Doximity, Inc. (DOCS)
| Market Cap | 4.76B -65.1% |
| Revenue (ttm) | 655.57M +11.2% |
| Net Income | 167.05M -29.0% |
| EPS | 0.84 -27.9% |
| Shares Out | 178.25M |
| PE Ratio | 31.68 |
| Forward PE | 18.74 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 371,619 |
| Open | 27.27 |
| Previous Close | 26.84 |
| Day's Range | 26.23 - 27.48 |
| 52-Week Range | 17.15 - 76.51 |
| Beta | 1.25 |
| Analysts | Hold |
| Price Target | 29.94 (+12.05%) |
| Earnings Date | Nov 5, 2026 |
About DOCS
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools... [Read more]
Financial Performance
In fiscal year 2026, Doximity's revenue was $644.86 million, an increase of 13.05% compared to the previous year's $570.40 million. Earnings were $196.05 million, a decrease of -12.16%.
Financial StatementsAnalyst Summary
According to 21 analysts, the average rating for DOCS stock is "Hold." The 12-month stock price target is $29.94, which is an increase of 12.05% from the latest price.
News
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Doximity, Inc. (DOCS)
Philadelphia, Pennsylvania--(Newsfile Corp. - September 18, 2026) - Grabar Law Office is investigating potential claims on behalf of long-term shareholders of Doximity, Inc. (NYSE: DOCS) concerning wh...
DOXIMITY, INC. (DOCS) INVESTOR ALERT Investors With Large Losses in Doximity, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acqui...
Doximity Transcript: AGM 2026
The meeting covered director elections, auditor ratification, and executive compensation approval. All proposals passed, with directors elected through 2029 and Deloitte confirmed as auditor for fiscal 2027.
Overworked Doctors Bet on AI to Boost Their Pay
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced new data indicating that physicians are finding an unexpected ...
Doximity stock is reversing post-earnings rally: why that shouldn't surprise you
Doximity (DOCS) stock as much as doubled on Friday morning after the digital platform for health care professionals posted a solid Q1 sales beat and issued seemingly impressive full-year guidance. Sti...
Here's Why Doximity Stock Is Flying Today
Shares of Doximity are rocking higher Friday. The reason?
Doximity's stock skyrockets 50% on medical AI excitement. Can the rally last?
While one analyst thinks Doximity has a compelling AI opportunity, another worries that the company could cannibalize its core business of medical networking.
Shares of this digital medical platform were up more than 100% at one point. Here's what's driving it
Doximity had a solid first quarter and raised its full year revenue guidance. But AI search isn't baked into these forecasts, analysts believe, and it's bringing in 10 times the revenue it costs to ru...
Doximity Stock Soars Almost 80% After Earnings Miss—It's All About AI
Shares surge, even after the medical networking and telehealth company's earnings miss analysts' targets.
Doximity Earnings Call Transcript: Q1 2027
Revenue grew 7% year-over-year to $157M, with adjusted EBITDA margin at 48% and strong AI-driven momentum. AI Search and Scribe products are fueling new contracts and deeper client engagement, while guidance for FY27 was raised on robust demand and expanding enterprise adoption.
Doximity Earnings release: Q1 2027
Doximity released its Q1 2027 earnings on August 6, 2026, summarizing the period's financial results.
Doximity Quarterly report: Q1 2027
Doximity has published its Q1 2027 quarterly earnings report on August 6, 2026.
Doximity Announces Fiscal 2027 First Quarter Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 first quarter ended June 30, 2026. ...
Doximity Slides: Investor presentation
Doximity has posted slides in relation to its latest quarterly earnings report, which was published on August 1, 2026.
Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter e...
Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Doximity Ask, its HIPAA-compliant clinical AI platform, o...
Doximity Proxy statement: Proxy filing
Doximity filed a proxy statement on July 15, 2026, providing details for shareholder voting and corporate governance matters.
Doximity Proxy statement: Proxy filing
Doximity filed a proxy statement on July 15, 2026, providing details for shareholder voting and corporate governance matters.
Did Doximity Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
Doximity to Present at the William Blair 46th Annual Growth Stock Conference
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the Wil...
Doximity plunges 24% on weak guidance, analysts slash PTs on increased AI spending
Shares of Doximity (NYSE: DOCS) plunged on Thursday after the telehealth platform reported weaker-than-expected quarterly profit and issued fiscal 2027 revenue guidance that fell significantly short o...
Doximity Earnings Call Transcript: Q4 2026
Q4 and full-year results exceeded guidance, with strong free cash flow and accelerating AI engagement. FY27 guidance reflects modest revenue growth and continued AI investment, with minimal near-term AI revenue but strong long-term potential.
Doximity Earnings release: Q4 2026
Doximity released its Q4 2026 earnings on May 13, 2026, summarizing the period's financial results.
Doximity Annual report: Q4 2026
Doximity has published its Q4 2026 annual report on May 13, 2026.
Doximity Partners with Aledade to Bring Clinical AI to Value-Based Care Settings
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced an integration with Aledade, a physician‑led, national leader ...